Uric Acid as a Predictor of Adverse Maternal and Perinatal Outcomes in Women Hospitalized With Preeclampsia

Journal of Obstetrics and Gynaecology Canada

Volumn 36, Issue 10, 2014, Pages 870-877

  Livingston, Joel R ^a   Payne, Beth ^a   Brown, Mark ^b,e   Roberts, James M ^c,f   Côté, Anne Marie ^d   Magee, Laura A ^a   von Dadelszen, Peter ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ST GEORGE HOSPITAL   (Australia)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITÉ DE SHERBROOKE   (Canada)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Preeclampsia; Pregnancy outcome; Risk assessment; Uric acid

Indexed keywords

URIC ACID;

ADULT; ADVERSE OUTCOME; ARTICLE; COHORT ANALYSIS; FEMALE; GESTATIONAL AGE; HOSPITAL PATIENT; HUMAN; HYPERURICEMIA; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PERINATAL PERIOD; PREDICTIVE VALUE; PREECLAMPSIA; PREGNANCY OUTCOME; PROTEINURIA; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; URIC ACID BLOOD LEVEL; BLOOD; PREGNANCY; RISK FACTOR;

ADULT; COHORT STUDIES; FEMALE; HUMANS; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; RISK FACTORS; URIC ACID;

EID: 84925232326     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(15)30435-7     Document Type: Article

References (19)

1. Steegers E.A.P., von Dadelszen P., Duvekot J.J., Pijnenborg R. Pre-eclampsia. Lancet 2010, 376:631-644.
2. von Dadelszen P., Payne B., Li J., Ansermino J.M., Pipkin F.B., Côté A.M., et al. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet 2011, 377:219-227.
3. Payne B.A., Hutcheon J.A., Ansermino J.M., Hall D.R., Bhutta Z.A., Bhutta S.Z., et al. A risk prediction model for the assessment and triage of women with hypertensive disorders of pregnancy in low-resourced settings: the miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) Multi-country Prospective Cohort Study. PLoS Med 2014, 11(1):e1001589.
4. Kang D.H., Finch J., Nakagawa T., Karumanchi S.A., Kanellsi J., Granger J., et al. Uric acid, endothelial dysfunction and pre-eclampsia: searching for a pathogenetic link. J Hypertens 2004, 22:229-235.
5. Bainbridge S.A., Roberts J.M. Uric acid as a pathogenic factor in preeclampsia. Placenta 2008, 29(Suppl A):S67-72.
6. Martin A.C., Brown M.A. Could uric acid have a pathogenic role in pre-eclampsia?. Nat Rev Nephrol 2010, 6:744-748.
7. Koopmans C.M., van Pampus M.G., Groen H., Aarnoudse J.G., van den Berg P.P., Mol B.W. Accuracy of serum uric acid as a predictive test for maternal complications in preeclampsia: bivariate meta-analysis and decision analysis. Eur J Obstet Gynecol Reprod Biol 2009, 146:8-14.
8. Bellomo G., Venanzi S., Saronio P., Verdura C., Narducci P.L. Prognostic significance of serum uric acid in women with gestational hypertension. Hypertension 2011, 58:704-708.
9. Roberts J.M., Bodnar L.M., Lain K.Y., Hubel C.A., Markovic N., Ness R.B., et al. Uric acid is as important as proteinuria in identifying fetal risk in women with gestational hypertension. Hypertension 2005, 46(6):1263-1269.
10. Thangaratinam S., Ismail K.M., Sharp S., Coomarasamy A., Khan K.S. Accuracy of serum uric acid in predicting complications of preeclampsia: a systematic review. BJOG 2006, 113:369-378.
11. Williams K.P., Galerneau F. The role of serum uric acid as a prognostic indicator of the severity of maternal and fetal complications in hypertensive pregnancies. J Obstet Gynaecol Can 2002, 24:628-632.
12. Lind T., Godfrey K.A., Otun H. Changes in serum uric acid concentrations during normal pregnancy. Br J Obstet Gynaecol 1984, 91:128-132.
13. Hawkins T., Roberts J., Mangos G., Davis G., Roberts L., Brown M. Plasma uric acid remains a marker of poor outcome in hypertensive pregnancy: a retrospective cohort study. BJOG 2012, 119:484-492.
14. Royston P., Altman D.G. Visualizing and assessing discrimination in the logistic regression model. Stat Med 2010, 29:2508-2520.
15. Many A., Hubel C.A., Fisher S.J., Roberts J.M., Zhou Y. Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am J Pathol 2000, 156:321-331.
16. Bainbridge S.A., Von Versen-Hoynck F., Roberts J.M. Uric acid inhibits placental system A amino acid uptake. Placenta 2009, 30:195-200.
17. Bainbridge S.A., Roberts J.M., Von Versen-Hoynck F., Koch J., Edmunds L., Hubel C.A. Uric acid attenuates trophoblast invasion and integration into endothelial cell monolayers. Am J Physiol Cell Physiol 2009, 297:C440-50.
18. Payne B., Magee L.A., von Dadelszen P. Assessment, surveillance and prognosis in pre-eclampsia. Best Pract Res Clin Obstet Gynaecol 2011, 4:449-462.
19. Magee L.A., Pels A., Helewa M., Rey E., von Dadelszen P., on behalf of the Canadian Hypertensive Disorders of Pregnancy Working Group Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. Pregnancy Hypertens 2014, 4(2):105-145.